NURS 6630 FINAL EXAM 1 – QUESTION WITH ANSWERS (NURS 6630 FINAL EXAM 1 – QUESTION WITH ANSWERS)

Introduction to Neuroscience—Initial Post 1. Explain the agonist-to-antagonist spectrum of action of psychopharmacologic agents. The agonist-to- antagonist spectrum of action of psychopharmacologic agents refers to how certain drugs behave under specific biological and chemical conditions. There are four main categories of this spectrum that include: agonist, partial agonist, antagonist, and inverse agonist (Stahl, 2013). An agonist causes a conformational change that triggers a maximum ...

-

4 pages

Written in 2020/2021

Grade A+

kibetdav

NURS 6630 Final Exam (2018): Walden University – Question and Answers What will the PMHNP most likely prescribe to a patient with psychotic aggression who needs to manage the top-down cortical control and the excessive drive from striatal hyperactivity? The PMHNP is selecting a medication treatment option for a patient who is exhibiting psychotic behaviors with poor impulse control and aggression. Of the available treatments, which can help temper some of the adverse effects or symptoms th...

-

26 pages

Written in 2020/2021

Grade A+

abram23

Nurs 6630 Final Exam 1 – Question With Answers

-

26 pages

Written in 2021/2022

Grade A

LISSIE

Nurs Final Exam 1 Nurs Final Exam 3 Nurs Final Exam 4 Nurs Final Exam 5

-

4 items

abram23

The PMHNP is caring for a patient with fibromyalgia. Which second-line treatment does the PMHNP select that may be effective for managing this patient’s pain? The PMHNP is working with the student to care for a patient with diabetic peripheral neuropathic pain. The student asks the PMHNP why SSRIs are not consistently useful in treating this particular patient’s pain. What is the best response by the PMHNP? A patient is being prescribed bupropion and is concerned about the side effects. What...

-

17 pages

Written in 2020/2021

Grade A+

ScholarVaultPRO